Table of Contents
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-Q/A
Amendment No. 1
Amendment No. 1
(Mark One)
þ | QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
For the Quarterly Period Ended March 31, 2006 |
or
o | TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
For the transition period from to |
Commission file number 000-49839
Idenix Pharmaceuticals, Inc.
(Exact name of registrant as specified in its charter)
Delaware | 45-0478605 | |
(State or Other Jurisdiction of | (IRS Employer Identification No.) | |
Incorporation or Organization) |
60 Hampshire Street | ||
Cambridge, MA | 02139 | |
(Address of Principal Executive Offices) | (Zip Code) |
Registrant’s telephone number, including area code: (617) 995-9800
Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports) and (2) has been subject to such filing requirements for the past 90 days. Yesþ Noo
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer or a non-accelerated filer. See definition of “accelerated filer” and “large accelerated filer” in Rule 12b-2 of the Exchange Act.
Large Accelerated Filero | Accelerated Filerþ | Non-Accelerated Filero |
Indicate by check mark whether the registrant is a shell company (as defined by Rule 12b-2 of the Exchange Act). Yeso Noþ
As of June 6, 2006, the number of shares of the registrant’s common stock, par value $.001 per share, outstanding was 56,004,720 shares.
TABLE OF CONTENTS
SIGNATURES | ||||||||
Exhibit Index | ||||||||
EX-31.1 Section 302 Certification of CEO | ||||||||
EX-31.2 Section 302 Certification of CFO |
Table of Contents
EXPLANATORY NOTE
Idenix Pharmaceuticals, Inc. (the “Company”) is filing this Amendment No. 1 to its Quarterly Report on Form 10-Q for the quarter ended March 31, 2006 for the sole purpose of correcting inadvertent omissions from the Section 302 certifications included with the original Form 10-Q filed with the Securities and Exchange Commission on May 10, 2006. This Amendment No. 1 to Form 10-Q/A does not change or update the previously reported financial statements or any of the other disclosures included within the original Form 10-Q.
2
Table of Contents
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
Date: June 14, 2006 | By: | /s/ Jean-Pierre Sommadossi | ||
Jean-Pierre Sommadossi Chairman and Chief Executive Officer (Principal Executive Officer) | ||||
Date: June 14, 2006 | By: | /s/ David A. Arkowitz | ||
David A. Arkowitz Chief Financial Officer and Treasurer (Principal Accounting Officer) | ||||
Exhibit Index
Exhibit | ||
No. | Description | |
31.1 | Certification of Chief Executive Officer pursuant to Rule 13a-14(a)/Rule 15d-14(a) of the Securities Exchange Act of 1934, as amended. | |
31.2 | Certification of Chief Financial Officer pursuant to Rule 13a-14(a)/Rule 15d-14(a) of the Securities Exchange Act of 1934, as amended. |
3